Skip to content

Study · Not a test of the peptide alone · 2021

1 result

LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs.

Mestria S, Odoardi S, Frison G, Strano Rossi S

Drug testing and analysis16 Dec 2020Cited by 2 (Europe PMC)

PMID33245851 (opens in a new tab)DOI10.1002/dta.2986 (opens in a new tab)PepBankPUB-33245851
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Bremelanotide (PT-141) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Bremelanotide (PT-141).

  1. 01LabNot a test of Bremelanotide (PT-141) aloneOther designOther

    Liquid chromatography-high resolution mass spectrometry characterized bremelanotide, together with melanotan II, in eight unknown samples confiscated by police.

    In plain wordsIn lab tests, mass spectrometry identified bremelanotide in samples seized by police from the black market.

    Peptide
    Bremelanotide (PT-141)
    Outcome
    Not applicableIdentification of bremelanotide in confiscated black-market samples
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    We characterized the PIEDs melanotan II and bremelanotide, not legally marketed, in eight unknown samples confiscated by police together with anabolic steroids, hormone modulators, sexual enhancers and stimulants, intended for the black market of bodybuilders, using liquid chromatography-high resolu…

    In this study, Bremelanotide (PT-141) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Bremelanotide (PT-141).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 3 to 38Current

    28 Oct 2026, 02:04 UTC

    The same notice was added 36 times, first on 9 Oct 2026, 18:17 UTC. The status did not change between them.

    Study results updated

  2. Version 2

    9 Oct 2026, 03:04 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.